Acorda Therapeutics Inc Коэффициент "короткого" интереса
Что обозначает Коэффициент "короткого" интереса в Acorda Therapeutics Inc?
Коэффициент "короткого" интереса Acorda Therapeutics Inc является 0.25
Какое определение для Коэффициент "короткого" интереса?
Краткосрочный коэффициент - это количество проданных акций, которых нет в наличии, деленное на среднесуточный объем.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Коэффициент "короткого" интереса компаний в Health Care сектор на NASDAQ по сравнению с Acorda Therapeutics Inc
Что делает Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Компании с коэффициент "короткого" интереса похож на Acorda Therapeutics Inc
- Dgl Investments No 1 Inc имеет Коэффициент "короткого" интереса из 0.24
- Rockport Capital Corp имеет Коэффициент "короткого" интереса из 0.24
- KINS Technology имеет Коэффициент "короткого" интереса из 0.24
- Zions Bancorporation N.A имеет Коэффициент "короткого" интереса из 0.24
- Superconductor Technologies имеет Коэффициент "короткого" интереса из 0.24
- Neos Therapeutics Inc имеет Коэффициент "короткого" интереса из 0.24
- Acorda Therapeutics Inc имеет Коэффициент "короткого" интереса из 0.25
- Silicom Ltd имеет Коэффициент "короткого" интереса из 0.26
- Black Iron имеет Коэффициент "короткого" интереса из 0.26
- Wellfield Technologies Inc имеет Коэффициент "короткого" интереса из 0.26
- Devonian Health имеет Коэффициент "короткого" интереса из 0.26
- Bayhorse Silver имеет Коэффициент "короткого" интереса из 0.26
- Northern Superior Resources имеет Коэффициент "короткого" интереса из 0.26